Health Care [ 2/12 ] | Biotechnology [ 3/73 ]
NASDAQ | Common Stock
Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.
It develops Adrulipase, an oral, non-systemic, and biologic capsule that is in Phase 2 clinical trials for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF) and chronic pancreatitis (CP), as well as a recombinant lipase enzyme that enables the digestion of fats and other nutrients in CF and CP patients with EPI.
The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024.
Entero Therapeutics, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 29, 25 | -0.68 Increased by +93.27% | - |
| May 12, 25 | -0.28 Decreased by -174.05% | - |
| Mar 27, 25 | -2.59 Increased by +51.53% | - |
| Nov 11, 24 | -0.59 Increased by +93.63% | -0.32 Decreased by -83.00% |
| Aug 12, 24 | -10.10 Increased by +73.28% | -4.65 Decreased by -117.19% |
| May 14, 24 | 0.38 Increased by +100.35% | -2.43 Increased by +115.64% |
| Mar 18, 24 | -5.35 Increased by +97.77% | -4.03 Decreased by -32.75% |
| Nov 13, 23 | -9.20 Decreased by -100.84% | -12.30 Increased by +25.20% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by N/A% | -998.27 K Increased by +88.67% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -1.26 M Decreased by -122.62% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -12.24 M Decreased by -198.43% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.58 M Increased by +24.84% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.81 M Decreased by -110.25% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | 5.57 M Increased by +236.77% | Increased by +N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -4.10 M Decreased by -2.88% | Decreased by N/A% - |
| Sep 30, 23 | 0.00 Decreased by N/A% | -3.43 M Decreased by -178.20% | Decreased by N/A% - |